MedTrace Logo

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

NCT06026332 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 202

Last updated 2026-02-17

No results posted yet for this study

Summary

Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting

Conditions

Interventions

DRUG

ADSTILADRIN

Non-interventional

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Global Clinical Compliance · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2026-01-15
Completion
2026-01-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06026332 on ClinicalTrials.gov